Core Viewpoint - The incentive plan of Xiamen Tebao Biological Engineering Co., Ltd. involves the allocation of restricted stocks to 372 individuals, with a total of 1.2 million shares reserved for distribution, representing 0.29% of the total share capital at the time of the plan's submission to the shareholders' meeting [1] Group 1 - The total number of restricted stocks granted to the incentive recipients is 1.2 million shares [1] - The reserved shares account for 100% of the total reserved grant of restricted stocks [1] - The total number of shares involved in the incentive plan does not exceed 1% of the company's total share capital at the time of the plan's submission [1]

Core Viewpoint - The company has adjusted the grant price of the 2024 restricted stock incentive plan from 39.80 CNY per share to 39.18 CNY per share due to the implementation of the annual profit distribution plan [5][6][7]. Group 1: Decision-Making Process - The board of directors and the supervisory board approved the adjustment of the grant price during their respective meetings held on September 4, 2025 [1][5]. - The adjustment follows the procedures outlined in the company's 2024 restricted stock incentive plan draft and was authorized by the shareholders at the first extraordinary general meeting of 2024 [2][3]. Group 2: Adjustment Details - The adjustment was made based on the profit distribution plan approved at the 2024 annual general meeting, which included a cash dividend of 0.62 CNY per share [6]. - The formula used for the adjustment is P = P0 - V, where P0 is the original grant price, V is the cash dividend per share, and P is the adjusted grant price [6]. Group 3: Impact of Adjustment - The adjustment of the grant price is a result of the annual profit distribution and will not have a substantial impact on the company's financial status or operating results [6][7]. - The supervisory board confirmed that the adjustment complies with relevant regulations and does not harm the interests of the company or its shareholders [7]. Group 4: Legal Opinions - The company has obtained necessary approvals for the adjustment, ensuring compliance with relevant regulations and guidelines [7][8]. - The conditions for the reserved portion of the incentive plan have been met, and the company will continue to fulfill its information disclosure obligations as the incentive plan progresses [8].

Core Viewpoint - The Supervisory Board of Xiamen Tebao Biological Engineering Co., Ltd. has reviewed and approved the list of incentive recipients for the 2024 restricted stock incentive plan, confirming compliance with relevant laws and regulations [1][2]. Group 1: Compliance and Eligibility - All proposed incentive recipients meet the eligibility criteria outlined in the Management Measures, with no disqualifying conditions present [1]. - The list of incentive recipients excludes independent directors, supervisors, foreign employees, shareholders holding more than 5% of the company's shares, and immediate family members of the actual controller [2]. - The incentive recipients align with the scope defined in the draft of the 2024 restricted stock incentive plan approved by the company's first extraordinary general meeting of shareholders [2]. Group 2: Plan Details - The Supervisory Board has agreed to set September 4, 2025, as the date for the reserved grant of the incentive plan, with a grant price of 39.18 yuan per share for 1.2 million restricted shares to 372 recipients [2].

Core Viewpoint - The announcement details the results of the stock incentive plan for the first category of incentive objects' fourth vesting period and the second category's third vesting period, highlighting the failure of certain stocks to vest due to performance targets not being met and the departure of some incentive objects [1][8][9]. Group 1: Stock Incentive Plan Overview - The stock incentive plan was approved during the board meeting on May 28, 2020, and subsequently ratified by the shareholders on June 19, 2020 [1][3]. - The plan included a public notice period from June 1 to June 11, 2020, during which no objections were raised regarding the incentive objects [2]. Group 2: Vesting Results - For the first category of incentive objects, 38.825 thousand shares failed to vest due to 11 individuals leaving the company and the company's failure to meet the performance targets for the fourth vesting period [7][8]. - For the second category of incentive objects, 14.6025 thousand shares failed to vest due to one individual leaving and not meeting the performance targets for the third vesting period [8][9]. Group 3: Impact of Non-Vesting - The non-vesting of these shares is not expected to materially impact the company's financial status or operational results, nor will it affect the stability of the core management team [9].

Core Viewpoint - The legal opinion letter confirms that Nanjing Julong Technology Co., Ltd. has obtained the necessary approvals and authorizations for the adjustment and initial grant of the 2025 second phase restricted stock incentive plan, in compliance with relevant laws and regulations [4][11]. Summary by Sections Approval and Authorization - The company has completed the necessary procedures for the adjustment and initial grant of the incentive plan, including meetings of the compensation and assessment committee, board of directors, and supervisory board, all of which approved relevant proposals [4][5][6]. Adjustment of Grant Price - The grant price of the restricted stock was adjusted from 13.21 to 12.96 yuan per share due to a cash dividend distribution of 2.5 yuan per 10 shares, which was approved at the 2024 annual general meeting [7][8]. Grant Conditions - The initial grant conditions have been met, with no disqualifying events occurring for the incentive objects, such as negative audit opinions or regulatory penalties [9][11]. Grant Details - The initial grant date is set for September 5, 2025, with a grant price of 12.96 yuan per share for 635,000 shares to 10 incentive objects, as authorized by the board of directors [10][11].

证券代码：300644 证券简称：南京聚隆 公告编号：2025-102 债券代码：123209 债券简称：聚隆转债 南京聚隆科技股份有限公司 关于向 2025 年第二期限制性股票激励计划激励对象 首次授予限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： ? 限制性股票首次授予数量：63.50 万股 ? 限制性股票首次授予价格：12.96 元/股 ? 股权激励方式：第二类限制性股票 南京聚隆科技股份有限公司（以下简称"公司"）2025 年第二期限制性股票 激励计划规定的限制性股票首次授予条件已成就，根据公司 2025 年第二次临时 股东大会的授权，公司于 2025 年 9 月 5 日召开了第六届董事会第十七次会议， 会议审议通过了《关于向 2025 年第二期限制性股票激励计划激励对象首次授予 限制性股票的议案》，确定以 2025 年 9 月 5 日为首次授予日，向 10 名激励对象 授予限制性股票 63.50 万股，授予价格为 12.96 元/股。现将有关事项说明如下： 一、激励计划简述 （一）激励工具：第二类限制性股票 （二）标 ...

证券代码：688278 证券简称：特宝生物 公告编号：2025- 厦门特宝生物工程股份有限公司 关于向 2024 年限制性股票激励计划激励对象 授予预留部分限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 ? 限 制 性 股 票 预 留 授 予 数 量 ： 120.00 万 股 ， 占 目 前 公 司 股 本 总 额 重要内容提示： ? 股权激励方式：第二类限制性股票 ? 限制性股票预留授予日：2025 年 9 月 4 日 厦门特宝生物工程股份有限公司（以下简称"公司"）《2024 年限制性股 票激励计划（草案）》（以下简称"《激励计划（草案）》"或"本激励计划"） 规定的限制性股票授予条件已经成就，根据公司 2024 年第一次临时股东大会的 授权，公司于 2025 年 9 月 4 日分别召开第九届董事会第十一次会议和第九届监 事会第八次会议，审议通过了《关于向 2024 年限制性股票激励计划激励对象授 予预留部分限制性股票的议案》，确定 2025 年 9 月 4 日为预留授予日，以 39.18 元/股的授 ...

Key Points - The company issued 11,500,000 convertible bonds with a total amount of 115 million yuan, approved by the China Securities Regulatory Commission on September 23, 2019 [1] - The convertible bonds were listed and began trading on the Shenzhen Stock Exchange on October 21, 2019, under the code 128074 [1] - The initial conversion price was set at 17.06 yuan per share, effective from March 27, 2020, until September 23, 2025 [2] - The conversion price was adjusted to 16.97 yuan per share after a cash dividend distribution on August 25, 2020 [2] - Following another dividend distribution, the conversion price was further adjusted to 16.92 yuan per share, effective from August 2, 2024 [3] - The board proposed to lower the conversion price to 10.10 yuan per share, effective from March 7, 2025 [4] - The convertible bonds have conditional redemption clauses triggered if the company's stock price meets certain criteria, including a closing price above 130% of the conversion price for at least 15 trading days [5] - The redemption price is set at 101.8575 yuan per bond, including accrued interest, with a redemption date scheduled for August 28, 2025 [6][7] - A total of 5,292 bonds will be redeemed, amounting to a total payment of approximately 539,029.89 yuan [8] - Following the redemption, the bonds will be delisted from the Shenzhen Stock Exchange on September 8, 2025 [8]

Core Viewpoint - The company plans to sign a convertible debt investment agreement with Beijing Shunzao Technology Co., Ltd., aiming to provide financial support of 50 million RMB, which can be converted into equity under certain conditions, thereby securing future investment opportunities and enhancing cooperation [1][5][7]. Group 1: Agreement Details - The company intends to provide a one-time financial support of 50 million RMB to Beijing Shunzao, with a borrowing period of two years and an interest rate of 2.75% [5][14]. - If the company does not convert the debt into equity by the end of the borrowing period, Beijing Shunzao is obligated to repay the principal and interest [5][14]. - The agreement has been approved by the company's board and will be submitted for shareholder approval [6][20]. Group 2: Strategic Considerations - The primary purpose of the investment agreement is to capture development opportunities and lock in the investment valuation of Beijing Shunzao, which is a major customer of the company [2][18]. - The company aims to reduce future investment risks and enhance resource sharing and business opportunities through this agreement [2][18]. - The financial support is not expected to affect the company's normal business operations or fund usage [18][20]. Group 3: Financial and Operational Context - Beijing Shunzao has shown significant growth, with total assets of approximately 73.41 million RMB and total liabilities of about 70.90 million RMB as of June 30, 2025, indicating a high debt ratio of 96.58% [11][12]. - The company has a long-term cooperative relationship with Beijing Shunzao, primarily in the development and sales of cleaning appliances [7][12]. - The agreement is structured to allow for a potential equity conversion, contingent upon the fulfillment of specific conditions, which will be evaluated carefully by the company [19][20].

Group 1 - The company issued 11,500,000 convertible bonds with a total amount of 115,000 million yuan, which began trading on October 21, 2019 [1] - The initial conversion price for the bonds was set at 17.06 yuan per share, valid from March 27, 2020, to September 23, 2025 [2] - The conversion price was adjusted to 16.97 yuan per share effective from August 25, 2020, following a cash dividend distribution [2] Group 2 - The conversion price was further adjusted to 16.92 yuan per share effective from August 2, 2024, due to another cash dividend distribution [3] - The board proposed to lower the conversion price to 10.10 yuan per share, effective from March 7, 2025 [4] Group 3 - The company has conditional redemption terms for the convertible bonds, which can be triggered if the stock price remains above 130% of the conversion price for 15 out of 30 trading days [5] - The redemption price is set at 101.8575 yuan per bond, including accrued interest, with a current annual interest rate of 2% [6] Group 4 - As of the redemption registration date on August 27, 2025, there were 5,292 bonds remaining unconverted, and the total redemption amount will be 539,029.89 yuan [8] - The total face value of the redeemed bonds is 529,200.00 yuan, which represents a portion of the total issuance [8] Group 5 - Following the conversion of bonds, the company's total share capital increased by 94,887,294 shares, leading to a dilution of earnings per share in the short term [8] - The convertible bonds will be delisted from the Shenzhen Stock Exchange starting September 8, 2025 [8]